AEON confirmed that earlier today it held its BPD Type 2a Meeting with the FDA, in line with prior guidance, and is now awaiting official meeting minutes - - Separately, AEON shareholders today voted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback